BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 22227661)

  • 1. Targeting Huntingtin in Patients with Huntington's Disease.
    Sheikh SI; Guerciolini R
    N Engl J Med; 2019 Sep; 381(12):1181. PubMed ID: 31532969
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting Huntingtin in Patients with Huntington's Disease. Reply.
    Tabrizi SJ; Smith AV; Bennett CF
    N Engl J Med; 2019 Sep; 381(12):1181-1182. PubMed ID: 31532970
    [No Abstract]   [Full Text] [Related]  

  • 3. SIRT1 and SIRT2 Activity Control in Neurodegenerative Diseases.
    Manjula R; Anuja K; Alcain FJ
    Front Pharmacol; 2020; 11():585821. PubMed ID: 33597872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebellar Predominant Increase in mRNA Expression Levels of Sirt1 and Sirt3 Isoforms in a Transgenic Mouse Model of Huntington's Disease.
    Salamon A; Maszlag-Török R; Veres G; Boros FA; Vágvölgyi-Sümegi E; Somogyi A; Vécsei L; Klivényi P; Zádori D
    Neurochem Res; 2020 Sep; 45(9):2072-2081. PubMed ID: 32524313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of the Deacetylase SIRT1 in the Response to Nucleolar Stress: Metabolic Implications for Neurodegenerative Diseases.
    Kreiner G; Sönmez A; Liss B; Parlato R
    Front Mol Neurosci; 2019; 12():106. PubMed ID: 31110473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amelioration of Huntington's disease phenotypes by Beta-Lapachone is associated with increases in Sirt1 expression, CREB phosphorylation and PGC-1α deacetylation.
    Lee M; Ban JJ; Chung JY; Im W; Kim M
    PLoS One; 2018; 13(5):e0195968. PubMed ID: 29742127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirtuins Expression and Their Role in Retinal Diseases.
    Balaiya S; Abu-Amero KK; Kondkar AA; Chalam KV
    Oxid Med Cell Longev; 2017; 2017():3187594. PubMed ID: 28197299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodegeneration Alters Metabolic Profile and Sirt 1 Signaling in High-Fat-Induced Obese Mice.
    Lima LCF; Saliba SW; Andrade JMO; Cunha ML; Cassini-Vieira P; Feltenberger JD; Barcelos LS; Guimarães ALS; de-Paula AMB; de Oliveira ACP; Santos SHS
    Mol Neurobiol; 2017 Jul; 54(5):3465-3475. PubMed ID: 27181590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol: A Focus on Several Neurodegenerative Diseases.
    Tellone E; Galtieri A; Russo A; Giardina B; Ficarra S
    Oxid Med Cell Longev; 2015; 2015():392169. PubMed ID: 26180587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIRT1 in neurodevelopment and brain senescence.
    Herskovits AZ; Guarente L
    Neuron; 2014 Feb; 81(3):471-83. PubMed ID: 24507186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirtuin deacetylases in neurodegenerative diseases of aging.
    Herskovits AZ; Guarente L
    Cell Res; 2013 Jun; 23(6):746-58. PubMed ID: 23689277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets.
    Jiang M; Wang J; Fu J; Du L; Jeong H; West T; Xiang L; Peng Q; Hou Z; Cai H; Seredenina T; Arbez N; Zhu S; Sommers K; Qian J; Zhang J; Mori S; Yang XW; Tamashiro KL; Aja S; Moran TH; Luthi-Carter R; Martin B; Maudsley S; Mattson MP; Cichewicz RH; Ross CA; Holtzman DM; Krainc D; Duan W
    Nat Med; 2011 Dec; 18(1):153-8. PubMed ID: 22179319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Huntingtin-protein interactions and the pathogenesis of Huntington's disease.
    Li SH; Li XJ
    Trends Genet; 2004 Mar; 20(3):146-54. PubMed ID: 15036808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transducer of regulated CREB-binding proteins (TORCs) transcription and function is impaired in Huntington's disease.
    Chaturvedi RK; Hennessey T; Johri A; Tiwari SK; Mishra D; Agarwal S; Kim YS; Beal MF
    Hum Mol Genet; 2012 Aug; 21(15):3474-88. PubMed ID: 22589249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein aggregation in Huntington's disease.
    Hoffner G; Djian P
    Biochimie; 2002 Apr; 84(4):273-8. PubMed ID: 12106904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finding a sirtuin truth in Huntington's disease.
    La Spada AR
    Nat Med; 2012 Jan; 18(1):24-6. PubMed ID: 22227661
    [No Abstract]   [Full Text] [Related]  

  • 17. Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway.
    Jeong H; Cohen DE; Cui L; Supinski A; Savas JN; Mazzulli JR; Yates JR; Bordone L; Guarente L; Krainc D
    Nat Med; 2011 Dec; 18(1):159-65. PubMed ID: 22179316
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.